Actively Recruiting
Molecular Pituitary Imaging Using 18F-FET PET
Led by University of Cambridge · Updated on 2026-01-06
20
Participants Needed
1
Research Sites
121 weeks
Total Duration
On this page
Sponsors
U
University of Cambridge
Lead Sponsor
C
Cambridge University Hospitals NHS Foundation Trust
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this single centre pilot study is to explore whether 18F-fluoro-ethyl-tyrosine PET (FET-PET) yields comparable findings to 11C-methionine PET (Met-PET) for the localisation of pituitary tumours.
CONDITIONS
Official Title
Molecular Pituitary Imaging Using 18F-FET PET
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Willing and able to give informed consent for participation in the study
- Male or female aged 18 years or older
- Presence of pituitary adenoma suspected based on clinical, biochemical, or radiological findings
- Previous 11C-Methionine PET/CT scan performed
You will not qualify if you...
- Unable to provide informed consent
- Pregnancy or suspected pregnancy
- Unable to lie on back for 30 to 60 minutes
- Body size exceeding scanner limits
- Known allergy to intravenous radiographic contrast agents
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Cambridge University Hospitals
Cambridge, Cambridgeshire, United Kingdom, CB2 0QQ
Actively Recruiting
Research Team
J
James MacFarlane
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here